In order to investigate whether the metabolic changes induced by the FGF19-M52 analogue would translate in protection from HCC occurrence, macroscopic analysis of 16 months old Abcb4−/− mice liver was performed at the day of sacrifice. Here, ABCB4 is linked to hepatocellular carcinoma.